Clinical trial Recruiting at 1 site Interventional Ages 5 to 12

Training viewing strategies in children with visual impairment

Official title: Viewing Strategy Training in Children With (Cerebral) Visual Impairment: From Spontaneous Eye Movements to a Structured Viewing Strategy

Run by Royal Dutch Visio · NCT05600140 · Data updated 2026-11-12

This study tests if training can help children with visual impairments learn better viewing strategies compared to children with normal vision.

Quick facts

Study typeInterventional
Ages5 Years to 12 Years
SexAll
Enrollment60 (estimated)
SponsorRoyal Dutch Visio
Academic / other
Locations1 site (Nijmegen)
StatusRecruiting
StartedOctober 25, 2024
Main results expectedDecember 2026
Study endsDecember 2026
Registry record updatedJanuary 7, 2026
Trial IDNCT05600140 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include children aged 5-12 years with normal vision, ocular visual impairment, or cerebral visual impairment.

Probably not a fit

Patients with severe developmental disorders or psychiatric problems may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This project aims to investigate the viewing strategies used by children with normal vision compared to those with ocular visual impairment and cerebral visual impairment (CVI). It will measure how these strategies differ and evaluate the effectiveness of training programs designed to improve visual information processing. The study will involve children aged 5-12 years and will assess their visual acuity and cognitive abilities. The ultimate goal is to provide evidence for the effectiveness of viewing strategy training in clinical practice.

Why it matters

Potential benefit: If successful, this training could significantly enhance the visual processing abilities of children with visual impairments.

How similar studies have gone: While viewing strategy training is commonly used in practice, there is currently no scientific evidence supporting its effectiveness, making this approach relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion criteria typically developing children with normal vision:

* Age 5-12 years
* linear distant visual acuity of 0.1 logMAR or better
* Verbal IQ above 70
* Absence of developmental disorders or psychiatric problems like ASS or AD(H)D

Inclusion criteria for children with ocular visual impairment:

* Age 5-12 years
* Children with linear distance visual acuity better \<=1.3logMAR and \>0.1 logMAR
* Intact central visual field (at least \> 30 degrees)
* Children with a verbal IQ above 70
* Absence of developmental disorders or psychiatric problems like ASS or AD(H)D

Inclusion criteria for children with cerebral visual impairment:

* Age 5-12 years
* Linear distance visual acuity \<=0.3 logMAR
* Having the diagnosis CVI (verified by ophthalmologists)
* Children with a verbal IQ above 70
* Absence of psychiatric problems like ASS or AD(H)D

Additional inclusion criterion for study 2 (evaluating training effectiveness): children with (cerebral) visual impairment should have an indication for viewing strategy training. Training should not be indicated if children have no problems performing academic tasks (i.e. when speed and accuracy of visual processing is within the normal range). The age range for study 2 is 5-9 years.

Exclusion criteria:

* Children with VI: linear near visual acuity \>1.0 logMAR
* Children with visual field defect \< 30 degrees
* Children with a verbal IQ below 70
* Children who attended a form of vision training in the past two years
* Children with psychiatric problems like ASS or AD(H)D
* Auditory impairment or language impairments
* Major life events during training

Where it's running

  • Royal Dutch Visio
    Nijmegen, Netherlands
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Stair-edge contrast designs for older adults with vision impairment

    This project will test whether changing the contrast frequency on stair tread edges affects how older adults with and without vision impairment lift their feet when going up and down stairs.

    Recruiting The University of Alabama in Huntsville · Huntsville, Alabama · NCT07337317

  • Phentolamine eye drops for adults with reduced night vision after keratorefractive surgery

    This will test whether nightly phentolamine eye drops can improve low-light (mesopic) vision in adults who developed decreased vision after keratorefractive surgery.

    Recruiting at 20 sites Phase 3 Opus Genetics, Inc · Chandler, Arizona and 19 other locations · NCT07140783

  • Natural history of inherited retinal diseases

    This project will test whether color vision problems relate to retinal structure and visual function in people with inherited retinal dystrophies and in people without retinal disease.

    Recruiting Augelux Therapeutics · Wuhan · NCT07085533

  • Longitudinal analysis of spine and vision health in adolescents in Zhejiang

    This study looks at how common scoliosis and vision problems are in kids and teens aged 6-18 in Zhejiang, and tracks changes in their spine and eyesight over eight years while providing health education to help catch issues early.

    Recruiting Second Affiliated Hospital of Wenzhou Medical University · Wenzhou, Zhejiang · NCT06992622

  • Creating advanced tactile aids for blind individuals

    This study is testing new tactile aids made from special materials to see if they help blind and low vision individuals recognize objects better and faster than regular tactile aids.

    Recruiting University of Delaware · Newark, Delaware · NCT06237829

  • Using stem cells to treat retinal and optic nerve damage

    This study is testing if using stem cells from your own bone marrow can help improve vision in people with serious eye damage from conditions like age-related macular degeneration and optic nerve problems.

    Recruiting at 4 sites MD Stem Cells · Westport, Connecticut and 3 other locations · NCT03011541

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.